(Q43844115)

27 November 2017

Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer (English)

1 reference

27 November 2017

Thomas M Cardillo

1

1 reference

27 November 2017

Rosalyn Blumenthal

series ordinal

2

1 reference

27 November 2017

Zhiliang Ying

series ordinal

3

1 reference

27 November 2017

David V Gold

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

International Journal of Cancer

27 November 2017

1 reference

27 November 2017

97

1 reference

27 November 2017

386-392

1 reference

27 November 2017

3

1 reference

Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil

27 November 2017

1 reference

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

Radiosensitizing nucleosides

21 January 2018

1 reference

Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity

21 January 2018

1 reference

Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2.

21 January 2018

1 reference

New developments in monoclonal antibodies for cancer detection and therapy

21 January 2018

1 reference

Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer

21 January 2018

1 reference

Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma

21 January 2018

1 reference

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

21 January 2018

1 reference

2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase

21 January 2018

1 reference

Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin

21 January 2018

1 reference

A method of trace iodination of proteins for immunologic studies

21 January 2018

1 reference

Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model

21 January 2018

1 reference

Intra-arterial 5-bromodeoxyuridine and x-ray therapy

21 January 2018

1 reference

Maximizing therapeutic gain with gemcitabine and fractionated radiation

21 January 2018

1 reference

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

21 January 2018

1 reference

Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer

21 January 2018

1 reference

Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1613

1 reference

27 November 2017

1 reference